Haploidentical Bone Marrow Transplantation in 2015 and Beyond.

about

Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow-Review of Published Literature

P2860

Q26749454-DA2AB824-0B1D-4A1A-B126-DA68C7A8752C

P2860

Haploidentical Bone Marrow Transplantation in 2015 and Beyond.

Item

http://www.wikidata.org/entity/Q38607242

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Haploidentical Bone Marrow Transplantation in 2015 and Beyond.

@en

type

Item

label

Haploidentical Bone Marrow Transplantation in 2015 and Beyond.

@en

prefLabel

Haploidentical Bone Marrow Transplantation in 2015 and Beyond.

@en

P1476

Haploidentical Bone Marrow Transplantation in 2015 and Beyond.

@en

P2093

David Gómez-Almaguer

http://www.w3.org/2001/XMLSchema#string

Guillermo J Ruiz-Argüelles

http://www.w3.org/2001/XMLSchema#string

Guillermo J Ruiz-Delgado

http://www.w3.org/2001/XMLSchema#string

Oscar González-Llano

http://www.w3.org/2001/XMLSchema#string

P2860

Basiliximab.

Concise review: umbilical cord blood transplantation: past, present, and future

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Alemtuzumab for the prevention and treatment of graft-versus-host disease.

Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation.

Improving the clinical outcome of unmanipulated haploidentical blood and marrow transplantation.

Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM.

Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update.

Two decades of the oncologist.

Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.

P2888

s11912-015-0482-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-015-0482-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283277213

http://www.w3.org/2001/XMLSchema#string

P6179

1036630221

http://www.w3.org/2001/XMLSchema#string

P698

26467275

http://www.w3.org/2001/XMLSchema#string

Haploidentical Bone Marrow Transplantation in 2015 and Beyond.

about

P2860

P2860

Haploidentical Bone Marrow Transplantation in 2015 and Beyond.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698